Patient Blood Management Market Size by Product, Component, End-Users, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2029

5.7%
CAGR (2023-2029)
11.97 USD Bn.
Market Size
323
Report Pages
124
Market Tables

Overview

Patient Blood Management Market is expected to reach US$ 17.65 Bn. at a CAGR of 5.7% during the forecast period 2029.

Global Patient Blood Management Market Overview:

Patient Blood Management (PBM), a multidisciplinary approach adopted to limit the use of blood transfusion, minimizing blood loss at the time of surgical operations and optimizing the blood of the patient in all at-risk patients with the aim of improving their clinical outcomes. This is carried out by doctors for patients that possess the risk of blood loss at the time of surgical intervention. PBM has three main objectives:

Patient Blood Management MarketTo know about the Research Methodology :- Request Free Sample Report

1) Improving red cell mass, including treatments such as erythropoiesis-stimulating agents and iron and vitamin supplements.

2) Minimizing blood loss, by optimizing surgical and anesthetic techniques, treatment with tranexamic acid (TXA) and autologous blood salvage.

3) Harnessing and optimizing the tolerance of anaemia by promoting maximum pulmonary and cardiac function and the use of a restrictive transfusion threshold.

The report covers the detailed analysis of global Patient Blood Management System industry with the classifications of the market based on product, component and end-users. Analysis of past market dynamics from 2017 to 2021 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it.

The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Patient Blood Management Market Dynamics:

Rising demand for blood donation due to growing number of road accidents, trauma cases, increasing number of surgical procedures and rising prevalence of target diseases are the major factors contributing to the growth of market. Improved patient outcomes, faster recoveries and shorter stays in hospital, reduced patient exposure to the potential risks from receiving blood from another person also drive the market growth. The Patient blood Management has also shown benefits in the field of obstetrics for the treatment of anaemia, which occurs frequently during pregnancy, is mandatoryin order to improve maternal and foetal outcomes.
Also, rising awareness about the blood transfusion safety and adoption of patient blood management systems in developing economies is expected to provide a better growth opportunity in forecast period. According to the National Health Commission (NHC), the number of voluntary blood donations increasing from 328,000 in 1998 to 14.59 million in 2021.However, the high cost of the automated systems is likely to hamper the global market growth.

Global Patient Blood Management Market Regional Insights:

North America is expected to witness the lucrative market growth of xx% throughout the forecast period.

In terms of revenue, North America is expected to hold prominent share of patient blood management market followed by Europe during forecast period. Thanks to the increasing number of surgical procedures and rising incidences of target diseases like cancer, which requires the blood and blood products transfusion to make up the blood loss incurred during the procedures. Moreover, the presence of a large number of hospitals in the US is likely to support market growth. The US has over 7,200 active hospitals and a well-established healthcare sector.

In Europe, the market is driven by factors like well-established medical infrastructures and high number of road accidents where blood transfusion becomes the basic need. According to the Federal Statistical Office of Germany, the number of people injured in road accidents grew by 1.8% from November 2021 to November 2021. Along with this, surge in the preoperative anaemia has become a common factor in patients undergoing orthopedic and other major surgeries rises the demand for Patient Blood management in the region.However, there is a need for European healthcare providers to integrate PBM strategies into routine care for patients undergoing orthopaedic and other types of surgery in order to reduce the use of unnecessary transfusions and improve the quality of care.

Asia-Pacific is anticipated to grow at faster rate of xx%, owing to its rapidly developing healthcare sector, increasing patient pool and favorable government reimbursement policies.

Global Patient Blood Management Market Segment Analysis:

Based on the product type, the segment is further divided into instruments, accessories, reagents & kits and Software. According to the analysis, the instruments share is expected to dominate the market by registering a CAGR of xx% during forecast period.Thanks to increasing technological advancements, new product launches, increasing use of auto transfusion systemsduring surgeries and organ transplantation. It is further sub-segmented into blood processing, transfusion, diagnostics and storage devices.

Based on the component segment, the whole blood segment is anticipated to command the global market by xx%, due to increasing number of blood donor and donations worldwide. Also, rising prevalence of anaemia and blood cancer, which requires whole-blood unit and RBCs for transfusion will further propel the market growth.

Scope of the Global Patient Blood Management Market : Inquire before buying

Global Patient Blood Management Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 11.97 Bn.
Forecast Period 2023 to 2029 CAGR: 5.7% Market Size in 2029: US $ 17.65 Bn.
Segments Covered: by Product Instruments
Blood processing devices
Blood transfusion devices
Blood culture screening devices
Diagnostic & testing instruments
Blood storage devices
Accessories
Reagents & Kits
Software
by Component Whole Blood
Plasma
by End-Users Blood banks
Hospitals
Diagnostics & Pathology labs

Patient Blood Management Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players operating in Global Patient Blood Management Market:

1.Haemonetics Corporation
2.Fresenius Se & Co. KGaA
3.Terumo Corporation
4.Immucor, Inc.
5.B. Braun Melsungen AG
6.Macopharma
7.Biomérieux SA
8.Asahi Kasei Medical Co. Ltd.
9.Kaneka Corporation
10.Bio-Rad Laboratories, Inc.
11.Abbott Laboratories
12.Grifols, S.A.
13.F. Hoffmann-La Roche LTD.
14.Livanova PLC
15.Danaher Corporation
16.Haier Biomedical
17.BAG Diagnostics GmbH

The report also helps in understanding Global Patient Blood Management System Market dynamics, structure by analyzing the market segments and project the Global Patient Blood Management System Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Patient Blood Management System Market make the report investor’s guide.

Frequently Asked Questions:

1. Which region has the largest share in Global Patient Blood Management Market?
Ans: North America region holds the highest share in 2022.

2. What is the growth rate of Global Patient Blood Management Market?
Ans: The Global Patient Blood Management Market is growing at a CAGR of 5.7% during forecasting period 2023-2029.

3. What is scope of the Global Patient Blood Management market report?
Ans: Global Patient Blood Management Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Patient Blood Management market?
Ans: The important key players in the Global Patient Blood Management Market are – Haemonetics Corporation, Fresenius Se & Co. KGaA, Terumo Corporation, Immucor, Inc., B. Braun Melsungen AG, Macopharma, Biomérieux SA, Asahi Kasei Medical Co. Ltd., Kaneka Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Grifols, S.A., F. Hoffmann-La Roche LTD., Livanova PLC, Danaher Corporation, Haier Biomedical, and BAG Diagnostics GmbH

5. What is the study period of this market?
Ans: The Global Patient Blood Management Market is studied from 2022 to 2029.

Table of Contents

Global Patient Blood Management Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: PATIENT BLOOD MANAGEMENT Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast 6.1. PATIENT BLOOD MANAGEMENT Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product 7.4. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By Product 7.5. PATIENT BLOOD MANAGEMENT Market Analysis, By Product 7.6. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By Product 8. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast, By Component 8.1. Introduction and Definition 8.2. Key Findings 8.3. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component 8.4. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By Component 8.5. PATIENT BLOOD MANAGEMENT Market Analysis, By Component 8.6. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By Component 9. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast By End-Users 9.1. Introduction and Definition 9.2. Key Findings 9.3. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users 9.4. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By End-Users 9.5. PATIENT BLOOD MANAGEMENT Market Analysis, By End-Users 9.6. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By End-Users 10. Global PATIENT BLOOD MANAGEMENT Market Analysis, By Region 10.1. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Region 10.2. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By Region 10.3. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By Region 11. North America PATIENT BLOOD MANAGEMENT Market Analysis 11.1. Key Findings 11.2. North America PATIENT BLOOD MANAGEMENT Market Overview 11.3. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product 11.4. North America PATIENT BLOOD MANAGEMENT Market Forecast, By Product 11.4.1. Instruments 11.4.2. Accessories 11.4.3. Reagents & Kits 11.4.4. Software 11.5. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component 11.6. North America PATIENT BLOOD MANAGEMENT Market Forecast, By Component 11.6.1. Whole Blood 11.6.2. Plasma 11.7. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users 11.8. North America PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 11.8.1. Blood banks 11.8.2. Hospitals 11.8.3. Diagnostics & Pathology labs 11.9. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country 11.10. North America PATIENT BLOOD MANAGEMENT Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America PATIENT BLOOD MANAGEMENT Market Analysis, By Country 11.12. U.S. PATIENT BLOOD MANAGEMENT Market Forecast, By Product 11.12.1. Instruments 11.12.2. Accessories 11.12.3. Reagents & Kits 11.12.4. Software 11.13. U.S. PATIENT BLOOD MANAGEMENT Market Forecast, By Component 11.13.1. Whole Blood 11.13.2. Plasma 11.14. U.S. PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 11.14.1. Blood banks 11.14.2. Hospitals 11.14.3. Diagnostics & Pathology labs 11.15. Canada PATIENT BLOOD MANAGEMENT Market Forecast, By Product 11.15.1. Instruments 11.15.2. Accessories 11.15.3. Reagents & Kits 11.15.4. Software 11.16. Canada PATIENT BLOOD MANAGEMENT Market Forecast, By Component 11.16.1. Whole Blood 11.16.2. Plasma 11.17. Canada PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 11.17.1. Blood banks 11.17.2. Hospitals 11.17.3. Diagnostics & Pathology labs 11.18. Mexico PATIENT BLOOD MANAGEMENT Market Forecast, By Product 11.18.1. Instruments 11.18.2. Accessories 11.18.3. Reagents & Kits 11.18.4. Software 11.19. Mexico PATIENT BLOOD MANAGEMENT Market Forecast, By Component 11.19.1. Whole Blood 11.19.2. Plasma 11.20. Mexico PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 11.20.1. Blood banks 11.20.2. Hospitals 11.20.3. Diagnostics & Pathology labs 11.21. North America PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis 11.21.1. By Product 11.21.2. By Component 11.21.3. By End-Users 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe PATIENT BLOOD MANAGEMENT Market Analysis 12.1. Key Findings 12.2. Europe PATIENT BLOOD MANAGEMENT Market Overview 12.3. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product 12.4. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.4.1. Instruments 12.4.2. Accessories 12.4.3. Reagents & Kits 12.4.4. Software 12.5. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component 12.6. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.6.1. Whole Blood 12.6.2. Plasma 12.7. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users 12.8. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.8.1. Blood banks 12.8.2. Hospitals 12.8.3. Diagnostics & Pathology labs 12.9. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country 12.10. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.11.1. Instruments 12.11.2. Accessories 12.11.3. Reagents & Kits 12.11.4. Software 12.12. Germany PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.12.1. Whole Blood 12.12.2. Plasma 12.13. Germany PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.13.1. Blood banks 12.13.2. Hospitals 12.13.3. Diagnostics & Pathology labs 12.14. U.K. PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.14.1. Instruments 12.14.2. Accessories 12.14.3. Reagents & Kits 12.14.4. Software 12.15. U.K. PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.15.1. Whole Blood 12.15.2. Plasma 12.16. U.K. PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.16.1. Blood banks 12.16.2. Hospitals 12.16.3. Diagnostics & Pathology labs 12.17. France PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.17.1. Instruments 12.17.2. Accessories 12.17.3. Reagents & Kits 12.17.4. Software 12.18. France PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.18.1. Whole Blood 12.18.2. Plasma 12.19. France PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.19.1. Blood banks 12.19.2. Hospitals 12.19.3. Diagnostics & Pathology labs 12.20. Italy PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.20.1. Instruments 12.20.2. Accessories 12.20.3. Reagents & Kits 12.20.4. Software 12.21. Italy PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.21.1. Whole Blood 12.21.2. Plasma 12.22. Italy PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.22.1. Blood banks 12.22.2. Hospitals 12.22.3. Diagnostics & Pathology labs 12.23. Spain PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.23.1. Instruments 12.23.2. Accessories 12.23.3. Reagents & Kits 12.23.4. Software 12.24. Spain PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.24.1. Whole Blood 12.24.2. Plasma 12.25. Spain PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.25.1. Blood banks 12.25.2. Hospitals 12.25.3. Diagnostics & Pathology labs 12.26. Sweden PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.26.1. Instruments 12.26.2. Accessories 12.26.3. Reagents & Kits 12.26.4. Software 12.27. Sweden PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.27.1. Whole Blood 12.27.2. Plasma 12.28. Sweden PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.28.1. Blood banks 12.28.2. Hospitals 12.28.3. Diagnostics & Pathology labs 12.29. CIS countries PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.29.1. Instruments 12.29.2. Accessories 12.29.3. Reagents & Kits 12.29.4. Software 12.30. CIS countries PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.30.1. Whole Blood 12.30.2. Plasma 12.31. CIS countries PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.31.1. Blood banks 12.31.2. Hospitals 12.31.3. Diagnostics & Pathology labs 12.32. Rest of Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Product 12.32.1. Instruments 12.32.2. Accessories 12.32.3. Reagents & Kits 12.32.4. Software 12.33. Rest of Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Component 12.33.1. Whole Blood 12.33.2. Plasma 12.34. Rest of Europe PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 12.34.1. Blood banks 12.34.2. Hospitals 12.34.3. Diagnostics & Pathology labs 12.35. Europe PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis 12.35.1. By Component 12.35.2. By Product 12.35.3. By End-Users 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific PATIENT BLOOD MANAGEMENT Market Analysis 13.1. Key Findings 13.2. Asia Pacific PATIENT BLOOD MANAGEMENT Market Overview 13.3. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product 13.4. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.4.1. Instruments 13.4.2. Accessories 13.4.3. Reagents & Kits 13.4.4. Software 13.5. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component 13.6. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.6.1. Whole Blood 13.6.2. Plasma 13.7. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users 13.8. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.8.1. Blood banks 13.8.2. Hospitals 13.8.3. Diagnostics & Pathology labs 13.9. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country 13.10. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific PATIENT BLOOD MANAGEMENT Market Analysis, By Country 13.12. China PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.12.1. Instruments 13.12.2. Accessories 13.12.3. Reagents & Kits 13.12.4. Software 13.13. China PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.13.1. Whole Blood 13.13.2. Plasma 13.14. China PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.14.1. Blood banks 13.14.2. Hospitals 13.14.3. Diagnostics & Pathology labs 13.15. India PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.15.1. Instruments 13.15.2. Accessories 13.15.3. Reagents & Kits 13.15.4. Software 13.16. India PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.16.1. Whole Blood 13.16.2. Plasma 13.17. India PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.17.1. Blood banks 13.17.2. Hospitals 13.17.3. Diagnostics & Pathology labs 13.18. Japan PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.18.1. Instruments 13.18.2. Accessories 13.18.3. Reagents & Kits 13.18.4. Software 13.19. Japan PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.19.1. Whole Blood 13.19.2. Plasma 13.20. Japan PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.20.1. Blood banks 13.20.2. Hospitals 13.20.3. Diagnostics & Pathology labs 13.21. South Korea PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.21.1. Instruments 13.21.2. Accessories 13.21.3. Reagents & Kits 13.21.4. Software 13.22. South Korea PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.22.1. Whole Blood 13.22.2. Plasma 13.23. South Korea PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.23.1. Blood banks 13.23.2. Hospitals 13.23.3. Diagnostics & Pathology labs 13.24. Australia PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.24.1. Instruments 13.24.2. Accessories 13.24.3. Reagents & Kits 13.24.4. Software 13.25. Australia PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.25.1. Whole Blood 13.25.2. Plasma 13.26. Australia PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.26.1. Blood banks 13.26.2. Hospitals 13.26.3. Diagnostics & Pathology labs 13.27. ASEAN PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.27.1. Instruments 13.27.2. Accessories 13.27.3. Reagents & Kits 13.27.4. Software 13.28. ASEAN PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.28.1. Whole Blood 13.28.2. Plasma 13.29. ASEAN PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.29.1. Blood banks 13.29.2. Hospitals 13.29.3. Diagnostics & Pathology labs 13.30. Rest of Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Product 13.30.1. Instruments 13.30.2. Accessories 13.30.3. Reagents & Kits 13.30.4. Software 13.31. Rest of Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Component 13.31.1. Whole Blood 13.31.2. Plasma 13.32. Rest of Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 13.32.1. Blood banks 13.32.2. Hospitals 13.32.3. Diagnostics & Pathology labs 13.33. Asia Pacific PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis 13.33.1. By Product 13.33.2. By Component 13.33.3. By End-Users 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Analysis 14.1. Key Findings 14.2. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Overview 14.3. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product 14.4. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Product 14.4.1. Instruments 14.4.2. Accessories 14.4.3. Reagents & Kits 14.4.4. Software 14.5. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component 14.6. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Component 14.6.1. Whole Blood 14.6.2. Plasma 14.7. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users 14.8. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 14.8.1. Blood banks 14.8.2. Hospitals 14.8.3. Diagnostics & Pathology labs 14.9. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country 14.10. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Analysis, By Country 14.12. GCC Countries PATIENT BLOOD MANAGEMENT Market Forecast, By Product 14.12.1. Instruments 14.12.2. Accessories 14.12.3. Reagents & Kits 14.12.4. Software 14.13. GCC Countries PATIENT BLOOD MANAGEMENT Market Forecast, By Component 14.13.1. Whole Blood 14.13.2. Plasma 14.14. GCC Countries PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 14.14.1. Blood banks 14.14.2. Hospitals 14.14.3. Diagnostics & Pathology labs 14.15. South Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Product 14.15.1. Instruments 14.15.2. Accessories 14.15.3. Reagents & Kits 14.15.4. Software 14.16. South Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Component 14.16.1. Whole Blood 14.16.2. Plasma 14.17. South Africa PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 14.17.1. Blood banks 14.17.2. Hospitals 14.17.3. Diagnostics & Pathology labs 14.18. Nigeria PATIENT BLOOD MANAGEMENT Market Forecast, By Product 14.18.1. Instruments 14.18.2. Accessories 14.18.3. Reagents & Kits 14.18.4. Software 14.19. Nigeria PATIENT BLOOD MANAGEMENT Market Forecast, By Component 14.19.1. Whole Blood 14.19.2. Plasma 14.20. Nigeria PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 14.20.1. Blood banks 14.20.2. Hospitals 14.20.3. Diagnostics & Pathology labs 14.21. Egypt PATIENT BLOOD MANAGEMENT Market Forecast, By Product 14.21.1. Instruments 14.21.2. Accessories 14.21.3. Reagents & Kits 14.21.4. Software 14.22. Egypt PATIENT BLOOD MANAGEMENT Market Forecast, By Component 14.22.1. Whole Blood 14.22.2. Plasma 14.23. Egypt PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 14.23.1. Blood banks 14.23.2. Hospitals 14.23.3. Diagnostics & Pathology labs 14.24. Rest of Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Product 14.24.1. Instruments 14.24.2. Accessories 14.24.3. Reagents & Kits 14.24.4. Software 14.25. Rest of Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Component 14.25.1. Whole Blood 14.25.2. Plasma 14.26. Rest of Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 14.26.1. Blood banks 14.26.2. Hospitals 14.26.3. Diagnostics & Pathology labs 14.27. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis 14.27.1. By Product 14.27.2. By Component 14.27.3. By End-Users 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America PATIENT BLOOD MANAGEMENT Market Analysis 15.1. Key Findings 15.2. South America PATIENT BLOOD MANAGEMENT Market Overview 15.3. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product 15.4. South America PATIENT BLOOD MANAGEMENT Market Forecast, By Product 15.4.1. Instruments 15.4.2. Accessories 15.4.3. Reagents & Kits 15.4.4. Software 15.5. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component 15.6. South America PATIENT BLOOD MANAGEMENT Market Forecast, By Component 15.6.1. Whole Blood 15.6.2. Plasma 15.7. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users 15.8. South America PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 15.8.1. Blood banks 15.8.2. Hospitals 15.8.3. Diagnostics & Pathology labs 15.9. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country 15.10. South America PATIENT BLOOD MANAGEMENT Market Forecast, By Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America PATIENT BLOOD MANAGEMENT Market Analysis, By Country 15.12. Brazil PATIENT BLOOD MANAGEMENT Market Forecast, By Product 15.12.1. Instruments 15.12.2. Accessories 15.12.3. Reagents & Kits 15.12.4. Software 15.13. Brazil PATIENT BLOOD MANAGEMENT Market Forecast, By Component 15.13.1. Whole Blood 15.13.2. Plasma 15.14. Brazil PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 15.14.1. Blood banks 15.14.2. Hospitals 15.14.3. Diagnostics & Pathology labs 15.15. Colombia PATIENT BLOOD MANAGEMENT Market Forecast, By Product 15.15.1. Instruments 15.15.2. Accessories 15.15.3. Reagents & Kits 15.15.4. Software 15.16. Colombia PATIENT BLOOD MANAGEMENT Market Forecast, By Component 15.16.1. Whole Blood 15.16.2. Plasma 15.17. Colombia PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 15.17.1. Blood banks 15.17.2. Hospitals 15.17.3. Diagnostics & Pathology labs 15.18. Argentina PATIENT BLOOD MANAGEMENT Market Forecast, By Product 15.18.1. Instruments 15.18.2. Accessories 15.18.3. Reagents & Kits 15.18.4. Software 15.19. Argentina PATIENT BLOOD MANAGEMENT Market Forecast, By Component 15.19.1. Whole Blood 15.19.2. Plasma 15.20. Argentina PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 15.20.1. Blood banks 15.20.2. Hospitals 15.20.3. Diagnostics & Pathology labs 15.21. Rest of South America PATIENT BLOOD MANAGEMENT Market Forecast, By Product 15.21.1. Instruments 15.21.2. Accessories 15.21.3. Reagents & Kits 15.21.4. Software 15.22. Rest of South America PATIENT BLOOD MANAGEMENT Market Forecast, By Component 15.22.1. Whole Blood 15.22.2. Plasma 15.23. Rest of South America PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users 15.23.1. Blood banks 15.23.2. Hospitals 15.23.3. Diagnostics & Pathology labs 15.24. South America PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis 15.24.1. By Product 15.24.2. By Component 15.24.3. By End-Users 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Component, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Component 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Haemonetics Corporation 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Fresenius Se & Co. KGaA 16.3.3. Terumo Corporation 16.3.4. Immucor, Inc. 16.3.5. B. Braun Melsungen AG 16.3.6. Macopharma 16.3.7. Biomérieux SA 16.3.8. Asahi Kasei Medical Co. Ltd. 16.3.9. Kaneka Corporation 16.3.10. Bio-Rad Laboratories, Inc. 16.3.11. Abbott Laboratories 16.3.12. Grifols, S.A. 16.3.13. F. Hoffmann-La Roche LTD. 16.3.14. Livanova PLC 16.3.15. Danaher Corporation 16.3.16. Haier Biomedical 16.3.17. BAG Diagnostics GmbH 17. Primary key Insights

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample